title: IGF2-induced hypoglycemia unresponsive to everolimus.
authors.affiliation: Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Headington, Oxford OX3 7LE, UK. ashley.grossman@ocdem.ox.ac.uk.
authors.forename: T I M
authors.initials: TI
authors.lastname: Korevaar
authors.forename: F
authors.initials: F
authors.lastname: Ragazzoni
authors.forename: A
authors.initials: A
authors.lastname: Weaver
authors.forename: N
authors.initials: N
authors.lastname: Karavitaki
authors.forename: A B
authors.initials: AB
authors.lastname: Grossman
mesh_terms: D000306:Adrenal Cortex Neoplasms / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000378:metabolism; D018268:Adrenocortical Carcinoma / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000378:metabolism; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000068338:Everolimus; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000188:drug therapy / Q000209:etiology*; D007335:Insulin-Like Growth Factor II / Q000378:metabolism / Q000502:physiology*; D020123:Sirolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed
chemical_list: D000970:Antineoplastic Agents; D007335:Insulin-Like Growth Factor II; D000068338:Everolimus; D020123:Sirolimus